1. Home
  2. ULS vs BIO Comparison

ULS vs BIO Comparison

Compare ULS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UL Solutions Inc.

ULS

UL Solutions Inc.

HOLD

Current Price

$92.55

Market Cap

18.1B

Sector

N/A

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$332.07

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULS
BIO
Founded
1894
1952
Country
United States
United States
Employees
N/A
7450
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
18.1B
8.0B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ULS
BIO
Price
$92.55
$332.07
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$88.85
$339.75
AVG Volume (30 Days)
804.1K
285.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
N/A
EPS
0.45
N/A
Revenue
$3,053,000,000.00
N/A
Revenue This Year
$6.29
$2.74
Revenue Next Year
$5.67
$3.20
P/E Ratio
$203.64
$9.72
Revenue Growth
6.38
N/A
52 Week Low
$61.95
$236.73
52 Week High
$107.54
$343.12

Technical Indicators

Market Signals
Indicator
ULS
BIO
Relative Strength Index (RSI) 55.27 70.66
Support Level $85.43 $290.67
Resistance Level $103.03 $343.12
Average True Range (ATR) 2.38 9.95
MACD 0.92 2.38
Stochastic Oscillator 88.15 90.46

Price Performance

Historical Comparison
ULS
BIO

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: